Abstract
China Orthopedic Devices Medical Equipment Industry Report
Summary
This report is an essential source for in-depth information and data relating
to China Orthopedic Device market Broken Down to Categories, Segments. It also
offers detailed and comprehensive coverage of market revenue, volume,
distribution and company share information; and latest news, financial deals
and pipeline products information of each of the key segments of the
Orthopedic Devices Market in China.
Scope
・ The report provides sector information broken down into detailed categories
and segments in the region.
・ Total revenues, products sold, end users,
and average pricing.
・ Market shares of all the key competitors.
・
Key pipeline products that are set to shape the market, broken down by sector.
・ Information on the top medical equipment companies in the sector in the
country covering business description, strategic analysis, and financial
information.
・ Healthcare structure, regulatory environment, approval
process, pricing trends and reimbursement.
・ Product and brand updates,
strategy changes, R&D projects, corporate expansions and contractions and
regulatory changes.
・ Key mergers and acquisitions, partnerships, private
equity investments and IPOs.
・ Customer, hospitals and physicians
data.
Note: Some content types may not be available in this report
Reasons to buy
・ Gain a strong understanding of the industry at country level
・ Evaluate
and compare the attractiveness of the market in the country.
・ Identify
growth segments and opportunities in each industry sector within the
country.
・ Evaluate the pipeline of key products that will change the
sector, and identify threats and opportunities before the products are
launched in the country.
・ Analyze the competitiveness of the market in
the country and identify hotspots.
・ Develop strategies based on the
latest product, brand, expansion and research and development news in the
country.
・ Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
・ Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
Table of Contents
1 Table Of Contents 2
1.1 List Of Tables 16
1.2 List Of Figures 22
2 Introduction 27
2.1 What Is This Report
About? 27
2.2 Definitions 27
2.2.1 Orthopedic Devices 27
3
Healthcare Sector Review 31
3.1 Healthcare Expenditure 31
3.2
Healthcare Infrastructure 32
3.2.1 Healthcare Personnel Data 33
3.2.2
Healthcare Facilities Data 34
3.3 Healthcare Policy 37
4 Orthopedic
Devices in China 38
4.1 Orthopedic Devices Overall Revenues (2000-2012)
38
4.2 Orthopedic Devices Overall Volume (2000-2012) 45
4.3 Orthopedic
Devices Overall Company Share (2005-2006) 48
5 Joint Reconstruction in
China 49
5.1 Joint Reconstruction Overall Revenue (2000-2012) 49
5.1.1 Hip Replacement Overall Revenue (2000-2012) 55
5.1.2 Knee
Replacement Overall Revenue (2000-2012) 57
5.1.3 Shoulder Replacement
Overall Revenue (2000-2012) 59
5.1.4 Digits Replacement Overall Revenue
(2000-2012) 61
5.1.5 Elbow Replacement Overall Revenue (2000-2012) 63
5.1.6 Ankle Replacement Overall Revenue (2000-2012) 65
5.1.7 Wrist
Replacement Overall Revenue (2000-2012) 67
5.2 Joint Reconstruction
Overall Volume (2000-2012) 69
5.2.1 Hip Replacement Overall Volume
(2000-2012) 71
5.2.2 Knee Replacement Overall Volume (2000-2012) 73
5.2.3 Shoulder Replacement Overall Volume (2000-2012) 75
5.2.4 Digits
Replacement Overall Volume (2000-2012) 77
5.2.5 Elbow Replacement Overall
Volume (2000-2012) 79
5.2.6 Ankle Replacement Overall Volume (2000-2012)
81
5.2.7 Wrist Replacement Overall Volume (2000-2012) 83
5.3 Joint
Reconstruction Average Price (2000-2012) 85
5.3.1 Ankle Replacement
Average Price (2000-2012) 85
5.3.2 Wrist Replacement Average Price
(2000-2012) 87
5.3.3 Knee Replacement Average Price (2000-2012) 89
5.3.4 Hip Replacement Average Price (2000-2012) 91
5.3.5 Shoulder
Replacement Average Price (2000-2012) 93
5.3.6 Digits Replacement Average
Price (2000-2012) 95
5.4 Joint Reconstruction Distribution Share
(2005-2006) 97
5.5 Joint Reconstruction Company Share (2005-2006) 98
6
Orthobiologics in China 99
6.1 Orthobiologics Overall Revenues (2000-2012)
99
6.1.1 Bone Graft Substitutes Overall Revenues (2000-2012) 103
6.1.2 Bone Growth and Spinal Stimulation Overall Revenues (2000-2012) 105
6.1.3 Viscosupplementation Overall Revenues (2000-2012) 107
6.1.4 DBM
overall Revenues (2000-2012) 109
6.1.5 Bone Allografts Overall Revenues
(2000-2012) 111
6.2 Orthobiologics Overall Volume (2000-2012) 113
6.2.1 Bone Graft Substitutes Overall Volume (2000-2012) 117
6.2.2
Viscosupplementation Overall Volume (2000-2012) 119
6.2.3 Bone Growth and
Spinal Stimulation (2000-2012) 121
6.2.4 Bone Allografts Overall Volume
(2000-2012) 123
6.2.5 DBM Overall Volume (2000-2012) 125
6.3
Orthobiologics Average Price (2000-2012) 127
6.3.1 Bone Graft Substitute
Average Price (2000-2012) 127
6.3.2 Bone Allografts Average Price
(2000-2012) 129
6.3.3 DBM Average Price (2000-2012) 131
6.3.4 Bone
Growth and Spinal Stimulation Average Price (2000-2012) 133
6.3.5
Viscosupplementation Average Price (2000-2012) 135
6.4 Orthobiologics
Distribution Share (2005-2006) 137
6.5 Orthobiologics Company Share
(2005-2006) 137
7 Orthopedic Braces and Supports in China 139
7.1
Orthopedic Braces and Supports Overall Revenues (2000-2012) 139
7.1.1 Knee
Braces and Supports Overall Revenues (2000-2012) 143
7.1.2 Ankle Braces
and Supports Overall Revenues (2000-2012) 145
7.1.3 Wrist and Others
Overall Revenues (2000-2012) 147
7.2 Orthopedic Braces and Supports
Overall Volume (2000-2012) 149
7.2.1 Knee Braces and Supports Overall
Volume (2000-2012) 151
7.2.2 Ankle Braces and Supports Overall Volume
(2000-2012) 153
7.2.3 Wrist and Others Overall Volume (2000-2012) 155
7.3 Orthopedic Braces and Supports Average Price (2000-2012) 157
7.3.1
Knee Braces and Supports Average Price (2000-2012) 157
7.3.2 Ankle Braces
and Supports Average Price (2000-2012) 159
7.3.3 Wrist and Others Average
Price (2000-2012) 161
7.4 Orthopedic Braces and Supports Distribution
Share (2005-2006) 163
7.5 Orthopedic Braces and Supports Company Share
164
8 Spinal Surgery in China 165
8.1 Spinal Surgery Overall Revenues
(2000-2012) 165
8.1.1 Fusion Overall Revenues (2000-2012) 169
8.1.2
Non-Fusion Overall Revenues (2000-2012) 171
8.2 Spinal Surgery Overall
Volume (2000-2012) 173
8.2.1 Fusion Overall Volume (2000-2012) 175
8.2.2 Non-Fusion Overall Volume (2000-2012) 177
8.3 Spinal Surgery Average
Price (2000-2012) 179
8.3.1 Fusion Average Price (2000-2012) 179
8.3.2
Non-Fusion Average Price (2000-2012) 181
8.4 Spinal Surgery Distribution
Share (2005-2006) 183
8.5 Spinal Surgery Company Share (2005-2006) 184
9 Orthopedic Diagnostic Devices in China 185
9.1 Orthopedic Diagnostic
Devices Overall Revenues (2000-2012) 185
9.2 Orthopedic Diagnostic Devices
Overall Volume (2000-2012) 187
9.3 Orthopedic Diagnostic Devices Average
Price (2000-2012) 189
9.4 Orthopedic Diagnostic Devices Distribution
Share (2005-2006) 191
9.5 Orthopedic Diagnostic Devices Company Share
(2005-2006) 192
10 Trauma Fixation in China 194
10.1 Trauma Fixation
Overall Revenues (2000-2012) 194
10.1.1 Internal Fixators Overall Revenues
(2000-2012) 199
10.1.2 External Fixators Overall Revenues (2000-2012)
201
10.2 Trauma Fixation Overall Volume (2000-2012) 203
10.2.1
Internal Fixators Overall Volume (2000-2012) 205
10.2.2 External Fixators
Overall Volume (2000-2012) 207
10.3 Trauma Fixation Average Price
(2000-2012) 209
10.3.1 Internal Fixators Average Price (2000-2012) 209
10.3.2 External Fixators Average Price (2000-2012) 211
10.4 Trauma
Fixation Distribution Share (2005-2006) 213
10.5 Trauma Fixation Company
Share (2005-2006) 214
11 Orthopedic Accessories in China 216
11.1
Orthopedic Accessories Overall Revenues (2000-2012) 216
11.1.1 Bone
Cements Overall Revenues (2000-2012) 220
11.1.2 Cast Application and
Removal System Overall Revenues (2000-2012) 222
11.2 Orthopedic
Accessories Category Volume (2000-2012) 224
11.2.1 Cast Application and
Removal System Overall Volume (2000-2012) 226
11.2.2 Bone Cements Overall
Volume (2000-2012) 228
11.3 Orthopedic Accessories Average Price
(2000-2012) 230
11.3.1 Bone Cements Average Price (2000-2012) 230
11.3.2 Cast Application and Removal System Average Price (2000-2012) 232
11.4 Orthopedic Accessories Distribution Share (2005-2006) 234
11.5
Orthopedic Accessories Company Share (2005-2006) 235
12 DePuy, Inc.
Company Profile 236
12.1 Company Overview 236
12.2 Business Overview
236
12.2.1 Products: 237
12.2.2 History 238
12.3 Locations And
Subsidiaries 239
12.4 Financial Deals Landscape 241
12.4.1 Precimed
Acquires Chaumont Facility From Depuy 241
12.4.2 Symmetry Medical Acquires
Orthopedic Instrument Facility From DePuy 242
12.4.3 DePuy Mitek Acquires
Future Medical Systems 244
12.4.4 DePuy Orthopaedics Acquires Hand
Innovations 246
12.4.5 Archus Orthopedics Raises $35 Million In Series C
Financing 248
12.4.6 DePuy Spine Acquires Assets From The Bright Group
249
12.4.7 DePuy Spine To Acquire Assets From Disc-O-Tech Medical
Technologies 251
12.5 Recent Developments 253
12.5.1 Mar 10, 2008:
DePuy To Expand Cork Facility 253
12.6 DePuy, Inc. Pipeline Products
253
12.6.1 MOBILITY Total Ankle System 253
12.6.2 Polydioxanone Suture
(PDS) 256
12.6.3 CHARITE Artificial Disc 256
12.6.4 Delta Ceramax
258
12.6.5 Proxima 259
12.6.6 Cartilage Autograft Implantation System
261
12.6.7 PFC Sigma RP-F Knee 261
12.6.8 Compel 263
13 Stryker
Corporation Company Profile 264
13.1 Company Overview 264
13.2
Business Overview 264
13.2.1 MedSurg Equipment 264
13.2.2 Orthopaedic
Implants 265
13.2.3 Other 265
13.2.4 Major Products and Services
266
13.2.5 History 267
13.3 Value Chain Analysis 269
13.3.1
Manufacturing 270
13.3.2 Product Development 270
13.3.3 Sales and
Marketing 271
13.4 Financial and Operational Review 272
13.4.1
Financial Statements 272
13.4.2 Financial Ratios 273
13.4.3 Share
Holding Structure 274
13.5 SWOT Analysis 274
13.5.1 Stryker
Corporation Strengths 275
13.5.2 Stryker Corporation Weaknesses 275
13.5.3 Stryker Corporation Opportunities 276
13.5.4 Stryker Corporation
Threats 277
13.6 Locations And Subsidiaries 278
13.7 Financial Deals
Landscape 279
13.7.1 Stryker Sells Physiotherapy Associates To Water
Street Healthcare 279
13.7.2 Stryker Acquires Sightline Technologies
281
13.7.3 Stryker Acquires Plasmasol 282
13.7.4 Stryker Signs An
Agreement With Corin Group 284
13.7.5 Stryker Acquires Etrauma 285
13.7.6 Stryker Acquires SpineCore 287
13.7.7 LifeCell Signs An Agreement
With Stryker Howmedica Osteonics 289
13.8 Recent Developments 290
13.8.1 Jan 23, 2008: Stryker Declares Q4 2007 Results 290
13.8.2 Dec 18,
2007: Stryker To Declare Q4 2007 Operating Results 292
13.8.3 Dec 06,
2007: Stryker Increases Annual Dividend 292
13.8.4 Oct 17, 2007: Stryker
Declares Q3 2007 Results 292
13.8.5 Jul 19, 2007: Stryker Declares Q2 2007
Results 293
13.8.6 Apr 18, 2007: Stryker Declares Q1 2007 Results 294
13.8.7 Mar 26, 2007: Stryker To Expand Sales In India 295
13.8.8 Jan 25,
2007: Stryker Declares Year-End 2006 Results 295
13.8.9 Jan 25, 2007:
Stryker Declares Q4 2006 Results 297
13.8.10 Dec 06, 2006: Stryker
Declares Dividend 298
13.8.11 Oct 17, 2006: Stryker Declares Q3 2006
Results 298
13.8.12 Jul 27, 2006: Stryker Elects Additional Director
299
13.8.13 Jul 20, 2006: Stryker Declares Q2 2006 Results 299
13.9
Stryker Corporation Pipeline Products 301
13.9.1 FlexiCore 301
13.9.2
GEM OS2 Bone Graft Putty 301
13.9.3 Aquarelle 302
13.9.4 Cervicore
Artificial Cervical Disc 302
13.9.5 OP 1 Putty- transforaminal lumbar
interbody fusions 304
13.9.6 OP 1- cartilage regeneration 305
14
Medtronic, Inc. Company Profile 306
14.1 Company Overview 306
14.2
Business Overview 306
14.2.1 Cardiac Surgery 306
14.2.2 CRDM 307
14.2.3 Diabetes 307
14.2.4 ENT 308
14.2.5 Neurological 308
14.2.6
Physio-Control 309
14.2.7 Spinal and Navigation 309
14.2.8 Vascular
310
14.2.9 Major Products and Services 311
14.2.10 History 311
14.3 Value Chain Analysis 314
14.3.1 Manufacturing 315
14.3.2 Product
Development 315
14.3.3 Sales and Marketing 316
14.4 SWOT Analysis
316
14.4.1 Medtronic, Inc. Strengths 317
14.4.2 Medtronic, Inc.
Weaknesses 317
14.4.3 Medtronic, Inc. Opportunities 318
14.4.4
Medtronic, Inc. Threats 318
14.5 Financial and Operational Review 320
14.5.1 Financial Statements 320
14.5.2 Financial Ratios 321
14.6
Locations And Subsidiaries 321
14.7 Financial Deals Landscape 323
14.7.1 Medtronic Enters Into Licensing Agreement With Arbor Surgical
Technologies 323
14.7.2 REVA Medical Secures $42 Million In Financing
324
14.7.3 CardioMEMS Secures $33 Million In Series E Financing 326
14.7.4 Mitralign Secures $24 Million In Series C Financing 328
14.7.5
Medtronic Acquires Kyphon 330
14.7.6 Medtronic Acquires MRI Safety Patents
From Biophan 332
14.7.7 Bayer HealthCare Diabetes Care Signs An Agreement
With Medtronic 333
14.7.8 Alpine Acquires Neurodiagnostic Product Line
From Medtronic 335
14.7.9 Medtronic Signs An Agreement With Axon Systems
336
14.7.10 Medtronic Acquires O-arm Imaging System Assets From Breakaway
Imaging 338
14.7.11 Alpine Biomed Acquires Gastroenterology Diagnostics
Product Line From Medtronic 339
14.7.12 Innerpulse Announces Closing Of
$50 Million Series C Round 341
14.8 Recent Developments 341
14.8.1 Mar
19, 2008: FDA Calls Medtronic Drug Pump Warning Class I 341
14.8.2 Mar 05,
2008: Recent Medical Device Recall Indicates Need For Patient Protections
342
14.8.3 Mar 03, 2008: Medtronic Pays Akin Gump $140,000 To Lobby
343
14.8.4 Mar 01, 2008: Medtronic And Other Device Makers Support
Disclosure Of Payments To Doctors 343
14.8.5 Feb 27, 2008: Medtronic
Spends $1.7 Million On Lobbying In 2007 344
14.8.6 Feb 27, 2008: Medtronic
Announces First Human Use Of Its Bifurcation Stent 345
14.8.7 Feb 26,
2008: Medtronic Says Sunshine Act Should Go Further 346
14.8.8 Feb 22,
2008: Medtronic Elects New Board Member 346
14.8.9 Feb 21, 2008: Medtronic
Board Approves Quarterly Cash Dividend 346
14.8.10 Feb 21, 2008: Medtronic
Approves Cash Dividend 347
14.8.11 Feb 20, 2008: US Supreme Court Shields
Medical Device Manufacturers From Consumer Lawsuits 347
14.8.12 Feb 19,
2008: Medtronic Declares Q3 Fiscal 2008 Results 347
14.8.13 Feb 08, 2008:
Medtronic To Declare Q3 Fiscal 2008 Results 349
14.8.14 Feb 08, 2008:
Medtronic to Announce Financial Results for Its Third Quarter 349
14.8.15
Jan 28, 2008: Medtronic, Arbor Announce Exclusive Licensing Agreement 349
14.8.16 Jan 10, 2008: Medtronic Foundation Announces New Grant Guidelines For
Its HeartRescue Program 350
14.8.17 Dec 21, 2007: Medtronic Resolves
Marquis Defibrillator Lawsuits 350
14.8.18 Dec 17, 2007: Medtronic And
Weigao Announce Joint Venture In China 351
14.8.19 Nov 19, 2007: Medtronic
Declares Q2 Fiscal 2008 Results 352
14.8.20 Nov 15, 2007: Brower Piven
Announces Class Action Lawsuit Against Medtronic 353
14.8.21 Nov 12, 2007:
Medtronic To Declare Q2 Fiscal 2008 Results 353
14.8.22 Oct 19, 2007:
Medtronic Approves Cash Dividend 353
14.8.23 Aug 23, 2007: Medtronic
Elects New President And CEO 353
14.8.24 Aug 23, 2007: Medtronic Declares
Quarterly Dividend 353
14.8.25 Aug 21, 2007: Medtronic Declares Q1 Fiscal
2008 Results 354
14.8.26 Jun 22, 2007: Medtronic Elects New Directors
354
14.8.27 Jun 22, 2007: Medtronic Declares Quarterly Dividend 355
14.8.28 May 25, 2007: Biocompatibles Enters Agreement With Abbott 355
14.8.29 May 22, 2007: Medtronic Declares Q4 Fiscal 2007 Results 355
14.8.30 May 07, 2007: Biosense Announce Strategic Alliance With Medtronic
356
14.8.31 Feb 20, 2007: Medtronic Declares Q3 Fiscal 2007 Results
357
14.8.32 Jan 18, 2007: Medtronic Declares Quarterly Dividend 357
14.8.33 Jan 18, 2007: Medtronic Elects New Board Member 357
14.8.34 Jan
23, 2006: Edwards Lifesciences and Medtronic Settles Infringement Lawsuit
358
14.9 Medtronic, Inc. Pipeline Products 358
14.9.1 BRYAN Cervical
Disc 358
14.9.2 Endeavor Drug-Eluting Stent 361
14.9.3 Medtronic
Implantable Cardioverter Defibrillators 364
14.9.4 EnRhythm MRI SureScan
Pacing System 366
14.9.5 DIAM Spinal Stabilization System 369
14.9.6
Endurant Stent Graft System 371
14.9.7 Talent Thoracic Stent Graft System
373
14.9.8 PIVOTAL AAA 375
14.9.9 Exponent RX Self-Expanding Carotid
Stent 375
14.9.10 GuardWire embolic protection system 376
14.9.11 Deep
Brain Stimulation (DBS) therapy 377
14.9.12 Melody Transcatheter Pulmonary
Valve 377
14.9.13 Chronicle ICD 378
14.9.14 Advantage Supra 379
14.9.15 Pulmonic TCV 380
14.9.16 Percutaneous AAA 381
14.9.17 TGF Beta
1 Stent 381
14.9.18 Cinched Mosaic 381
14.9.19 LAA Occluder Band
382
14.9.20 Prestige LP 382
14.9.21 A-Mav 384
14.9.22 Interceptor
PLUS Coronary Filter System 384
14.9.23 Sprint Quattro(Model 6944) 385
14.9.24 Sprint Quattro(Model 6947) 386
14.9.25 Valiant Thoracic Stent
Graft 387
14.9.26 Intercept Epilepsy Control System 389
14.9.27
Bifurcation stent 391
14.9.28 Single-coil Quattro lead 395
14.9.29
Next Generation Insulin Pump 395
14.9.30 Pre-filled Insulin Reservoirs
396
14.9.31 Implantable Insulin Pump 396
15 Zimmer Holdings, Inc.
Company Profile 397
15.1 Company Overview 397
15.2 Business Overview
397
15.2.1 Americas 397
15.2.2 Asia Pacific 397
15.2.3 Europe
398
15.2.4 Major Products and Services 398
15.2.5 History 399
15.3
Value Chain Analysis 401
15.3.1 Manufacturing 401
15.3.2 Product
Development 401
15.3.3 Sales and Marketing 402
15.4 SWOT Analysis
403
15.4.1 Zimmer Holdings, Inc. Strengths 403
15.4.2 Zimmer Holdings,
Inc. Weaknesses 404
15.4.3 Zimmer Holdings, Inc. Opportunities 404
15.4.4 Zimmer Holdings, Inc. Threats 405
15.5 Financial and Operational
Review 407
15.5.1 Financial Statements 407
15.5.2 Financial Ratios
408
15.6 Locations And Subsidiaries 408
15.7 Financial Deals Landscape
410
15.7.1 Zimmer Holdings Acquires ORTHOsoft 410
15.7.2 Regeneration
Technologies And Zimmer Holdings Enter Into Distribution Agreement 411
15.7.3 Zimmer Holdings Acquires Endius 413
15.7.4 Zimmer Holdings Signs
Distribution Agreement With Brasseler USA 414
15.7.5 Zimmer Holdings
Expands Distribution Agreement With Heraeus Kulzer 416
15.7.6 ISTO
Technologies Completes $10.8 Million Financing 417
15.7.7 Zimmer Holdings
Enters Into An Agreement With Ohio Orthopedic Surgery Institute 419
15.7.8
Zimmer Holdings Signs An Agreement With Heraeus Kulzer 420
15.7.9 Zimmer
Holdings Acquires Implex 421
15.8 Recent Developments 423
15.8.1 Apr
01, 2008: Zimmer Holdings Announces Live Audio Webcast and Conference Call of
First Quarter 2008 Results 423
15.8.2 Mar 17, 2008: Zimmer Holdings, Inc.
Adds Robert Hagemann and Cecil Pickett to Board of Directors 423
15.8.3
Mar 17, 2008: Zimmer Announces Board Changes 425
15.8.4 Feb 05, 2008:
Zimmer To Expand Manufacturing Network In Ireland 425
15.8.5 Jan 29, 2008:
Zimmer Declares Q4 2007 Results 426
15.8.6 Nov 27, 2007: Zimmer Chiarman
To Resign, McGoldrick To Serve As Non-Executive Chairman 426
15.8.7 Oct
24, 2007: Zimmer Declares Q3 2007 Results 426
15.8.8 Jul 25, 2007: Zimmer
Declares Q2 2007 Results 427
15.8.9 May 04, 2007: Zimmer To Expand
Manufacturing And Distribution Facilities 428
15.8.10 May 01, 2007: Zimmer
Announces CEO And President 428
15.8.11 Apr 25, 2007: Zimmer Reports Q1
2007 Results 429
15.8.12 Feb 13, 2007: Zimmer Names Arthur Higgins To
Board 430
15.8.13 Jan 29, 2007: Zimmer Reports Q4 2006 Results 430
15.8.14 Dec 13, 2006: Zimmer Issues 2007 Sales And Earnings Guidance 431
15.8.15 Dec 12, 2006: Zimmer Announces Share Buyback Program 431
15.8.16
Nov 20, 2006: Zimmer' s President And CEO Plans To Retire 431
15.8.17 Nov
15, 2006: Zimmer To Support Board Declassification 431
15.8.18 Oct 25,
2006: Zimmer Reports Q3 2006 Results 432
15.8.19 Sep 18, 2006: Zimmer
Amends By-Laws 433
15.8.20 Jul 27, 2006: Zimmer Enters Distribution
Agreement With Brasseler 433
15.8.21 Jul 26, 2006: Zimmer Reports Q2 2006
Results 433
15.8.22 Jun 13, 2006: Zimmer, Burrell To Develop Information
Campaign 434
15.9 Zimmer Holdings, Inc. Pipeline Products 435
15.9.1
Denovo ET 435
15.9.2 Newcleus 436
15.9.3 Dynesys System 437
15.9.4
Durom Full Resurfacing Hip 437
15.9.5 BRIGIT Bone Resection Instrument
Guide 437
15.9.6 Natural-Knee II High-Flex Gender 439
15.9.7 NexGen
LPS-Flex Mobile Knee 439
16 Biomet, Inc. Company Profile 441
16.1
Company Overview 441
16.2 Business Overview 441
16.2.1 Fixation Device
Category 441
16.2.2 Other Products Category 441
16.2.3 Reconstructive
Products Category 442
16.2.4 Spinal Products Category 442
16.2.5 Major
Products and Services 442
16.2.6 History 443
16.3 Value Chain Analysis
444
16.3.1 Manufacturing 445
16.3.2 Product Development 445
16.3.3
Sales and Marketing 446
16.4 SWOT Analysis 447
16.4.1 Biomet, Inc.
Strengths 447
16.4.2 Biomet, Inc. Weaknesses 448
16.4.3 Biomet, Inc.
Opportunities 448
16.4.4 Biomet, Inc. Threats 449
16.5 Financial and
Operational Review 450
16.5.1 Financial Statements 450
16.5.2
Financial Ratios 451
16.5.3 Share Holding Structure 452
16.6 Locations
And Subsidiaries 452
16.7 Financial Deals Landscape 455
16.7.1
Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts And
TPG Acquires Biomet 455
16.7.2 Biomet And Diamicron Enter Into Development
And Distribution Agreement 456
16.7.3 Biomet Acquires Interpore
International 457
16.7.4 Biomet Acquires Biomet-Merck From Merck 459
16.7.5 Smith & Nephew Terminates Acquisition Of Biomet 461
16.8 Recent
Developments 462
16.8.1 Feb 29, 2008: Biomet Appoints New President,
Orthopedics Division 462
16.8.2 Jan 10, 2008: Biomet Declares Q2 Fiscal
2008 Results 462
16.8.3 Oct 15, 2007: Biomet Declares Q1 Fiscal 2008
Results 463
16.8.4 Jul 09, 2007: Biomet Declares Q4 Fiscal 2007 Results
464
16.8.5 May 21, 2007: Biomet And Massachusetts General Hospital Form
Research Alliance 466
16.8.6 May 14, 2007: Biomet Appoints New CFO 466
16.8.7 Apr 13, 2007: NASDAQ Grants Continued Listing To Biomet 467
16.8.8
Apr 04, 2007: Biomet Announces Senior Management Changes 467
16.8.9 Mar
08, 2007: Biomet Introduces NanoTite Dental Implant Technology 467
16.8.10
Feb 26, 2007: Biomet Appoints President And CEO 467
16.8.11 Feb 05, 2007:
Biomet Announces Licensing Agreement 467
16.8.12 Dec 18, 2006: Biomet
Announces Preliminary Unaudited Net Sales For Q2 2006 467
16.8.13 Dec 18,
2006: Biomet Announces Delay In Q2 Results 469
16.8.14 Sep 20, 2006:
Biomet Announces Q1 2006 Results 469
16.8.15 Aug 04, 2006: Biomet Retains
Services Of Heidrick & Struggles And The McLoughlin Company 471
16.8.16
Jul 12, 2006: Biomet Announces Senior Management Changes 471
16.8.17 Jun
28, 2006: Biomet Declares Dividend 471
16.8.18 Jun 28, 2006: Biomet
Reports Q4 2006 Results 471
16.9 Biomet, Inc. Pipeline Products 473
16.9.1 EBI Polymer Reinforced Pro Osteon 473
16.9.2 Rescue Cervical Disc
475
16.9.3 Regain 475
16.9.4 Min T Total Disc Replacement 476
16.9.5 Cobalt MV (Medium Viscosity) Bone Cement 476
16.9.6 OptiPac 477
16.9.7 OptiLock Distal Femoral Plating System 477
16.9.8 Distal Tibial
Plating System 478
16.9.9 VPC (Variable Pitch Compression) Screw System
478
16.9.10 Cobalt V Bone Cement 478
16.9.11 Allogenix Plus 479
16.9.12 ReCap Total Hip Resurfacing System 479
17 Regulation System
482
17.1 Medical Equipment Approval Process 482
17.1.1 Classification
482
17.1.2 Registration and Conformity assessment 483
17.1.3 China
Compulsory Certificate (CCC Mark) 485
17.1.4 Labeling and Packaging
486
17.1.5 Registration Fee 486
17.1.6 Registration Period 487
17.2 Post Market Surveillance (PMS) 487
18 Pricing and Reimbursement
488
19 Distribution Structure 490
20 APPENDIX 491
20.1 Methodology
491
20.2 Coverage 492
20.3 Secondary Research 492
20.4 Primary
Research 492
20.5 Models 493
20.6 Forecasts 493
20.7 Expert Panels
494
20.8 Currency Conversion 495
20.9 Contact Us 496
20.10
Disclaimer 496
